Altimmune, Inc. - Common Stock (ALT)

CUSIP: 02155H200

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class
Equity / Common Stock
Shares outstanding
104,413,190
Total 13F shares
1,032,457
Share change
-81,741
Total reported value
$2,456,382
Put/Call ratio
54%
Price per share
$2.37
Number of holders
15
Value change
-$456,118
Number of buys
9
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 02155H200?
CUSIP 02155H200 identifies ALT - Altimmune, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ALT - Altimmune, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
VANGUARD GROUP INC
13F
Company
0.35%
369,658
$1,072,000 31 Mar 2019
13F
Hudson Bay Capital Management LP
13F
Company
0.25%
261,806
$759,000 31 Mar 2019
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.12%
127,334
$369,000 31 Mar 2019
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.1%
109,306
$317,000 31 Mar 2019
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.07%
74,612
$216,000 31 Mar 2019
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.06%
57,560
$167,000 31 Mar 2019
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.05%
49,174
$142,000 31 Mar 2019
13F
Squarepoint Ops LLC
13F
Company
0.03%
33,866
$98,000 31 Mar 2019
13F
D. E. Shaw & Co., Inc.
13F
Company
0.01%
13,100
$38,000 31 Mar 2019
13F
CITADEL ADVISORS LLC
13F
Company
0.01%
13,081
$38,000 31 Mar 2019
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0%
3,700
$11,000 31 Mar 2019
13F
CWM, LLC
13F
Company
0%
1,025
$10,000 31 Mar 2019
13F
American Portfolios Advisors
13F
Company
0%
1,000
$2,900 31 Mar 2019
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0%
1
$3 31 Mar 2019
13F

Institutional Holders of Altimmune, Inc. - Common Stock (ALT) as of Q2 2019

As of 30 Jun 2019, Altimmune, Inc. - Common Stock (ALT) was held by 15 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,032,457 shares. The largest 10 holders included VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, BANK OF AMERICA CORP /DE/, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BlackRock Inc., SABBY MANAGEMENT, LLC, Bank of New York Mellon Corp, and CITADEL ADVISORS LLC. This page lists 15 institutional shareholders reporting positions in this security for the Q2 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders
13
Q2 2019 holders
15
Holder diff
2
Investor Q1 2019 Shares Q2 2019 Shares Share Diff Share Chg % Q1 2019 Value $ Q2 2019 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .